Evaluation is targeted at assessing the individual components of the<unk> . Labs to be drawn should include a:
CBC
May see a microangiopathic hemolytic anemia (Schistocytes on microscopy)
Platelet count <150 × 109 per L (150 per mm3)
Chemistry
Normal or elevated BUN/Cr
Coagulation panel (fibrinogen can be decreased and PTT elevated)
Patients can progress towards DIC
LFTs
AST levels > 150 IU/L and ALT levels > 100 IU/L (also often associated with bilirubin > 1.2mg/dL
LDH elevation (often > 600 IU/L)
UA (proteinuria)
CT or ultrasound can be considered if there is pain requiring a greater workup.
Depending on degree of thrombocytopenia are at risk for developing intraabdominal bleeding such as a hepatic hematoma
May see a microangiopathic hemolytic anemia (Schistocytes on microscopy)
Platelet count <150 × 109 per L (150 per mm3)
Normal or elevated BUN/Cr
Patients can progress towards DIC
AST levels > 150 IU/L and ALT levels > 100 IU/L (also often associated with bilirubin > 1.2mg/dL
LDH elevation (often > 600 IU/L)
Depending on degree of thrombocytopenia are at risk for developing intraabdominal bleeding such as a hepatic hematoma
HELLP syndrome
Amniotic fluid embolus
Acute fatty liver of pregnancy
Chorioamnionitis
Cholestasis of pregnancy
Antiphospholipid syndrome
Eclampsia
Preeclampsia